Senores Pharmaceuticals Ltd vs Shree Ganesh Remedies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 17, 2026

Key Highlights

The Latest Trading Price of Senores Pharmaceuticals Ltd is ₹ 1052 as of 15 May 15:30 . The P/E Ratio of Senores Pharmaceuticals Ltd changed from 45 on March 2025 to 0 on March 2023 . This represents a CAGR of -100.00% over 3 yearsThe P/E Ratio of Shree Ganesh Remedies Ltd changed from 30.5 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 4 years The Market Cap of Senores Pharmaceuticals Ltd changed from ₹ 2637 crore on March 2025 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 3 yearsThe Market Cap of Shree Ganesh Remedies Ltd changed from ₹ 801.21 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 4 years The revenue of Senores Pharmaceuticals Ltd for the Mar '26 is ₹ 192.86 crore as compare to the Dec '25 revenue of ₹ 178.34 crore. This represent the growth of 8.14% The revenue of Shree Ganesh Remedies Ltd for the Mar '26 is ₹ 34.22 crore as compare to the Dec '25 revenue of ₹ 21.76 crore. This represent the growth of 57.26% The ebitda of Senores Pharmaceuticals Ltd for the Mar '26 is ₹ 65.16 crore as compare to the Dec '25 ebitda of ₹ 57.79 crore. This represent the growth of 12.75% The ebitda of Shree Ganesh Remedies Ltd for the Mar '26 is ₹ 12.4 crore as compare to the Dec '25 ebitda of ₹ 7.39 crore. This represent the growth of 67.79% The net profit of Senores Pharmaceuticals Ltd changed from ₹ 10.91 crore to ₹ 36.67 crore over 8 quarters. This represents a CAGR of 83.33% The net profit of Shree Ganesh Remedies Ltd changed from ₹ 4.65 crore to ₹ 6.27 crore over 8 quarters. This represents a CAGR of 16.12% The Dividend Payout of Senores Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Shree Ganesh Remedies Ltd changed from 17.97 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Senores Pharmaceuticals Ltd

Senores Pharmaceuticals Limited was originally incorporated as 'Senores Pharmaceuticals Private Limited' through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre.
Thereafter, the name of the Company was changed to 'Senores Pharmaceuticals Limited' upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company. Senores Pharma is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for Regulated Markets across various therapeutic areas and dosage forms.
The Regulated Markets business is focused on Regulated Markets of US and Canada.
The Company has adopted a strategy of identifying, developing and commercializing specialty and complex niche products in the mid-market range and received approvals for 19 ANDAs.

About Shree Ganesh Remedies Ltd

Shree Ganesh Remedies Limited was originally incorporated as a Private Limited Company with the name 'Shree Ganesh Remedies Private Limited' at Ahmedabad, Gujarat on April 27, 1995.
Subsequently the Company was converted into a Public Limited and the name of the Company was changed to 'Shree Ganesh Remedies Limited' on July 28, 2017.
The Company, a part of Ganesh Group has carved for itself a niche in the industry of manufacturing pharmaceutical intermediates and fine chemicals. Shree Ganesh Remedies is a ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified Company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.
The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.

FAQs for the comparison of Senores Pharmaceuticals Ltd and Shree Ganesh Remedies Ltd

Which company has a larger market capitalization, Senores Pharmaceuticals Ltd or Shree Ganesh Remedies Ltd?

Market cap of Senores Pharmaceuticals Ltd is 4,846 Cr while Market cap of Shree Ganesh Remedies Ltd is 738 Cr

What are the key factors driving the stock performance of Senores Pharmaceuticals Ltd and Shree Ganesh Remedies Ltd?

The stock performance of Senores Pharmaceuticals Ltd and Shree Ganesh Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Senores Pharmaceuticals Ltd and Shree Ganesh Remedies Ltd?

As of May 17, 2026, the Senores Pharmaceuticals Ltd stock price is INR ₹1052.35. On the other hand, Shree Ganesh Remedies Ltd stock price is INR ₹575.6.

How do dividend payouts of Senores Pharmaceuticals Ltd and Shree Ganesh Remedies Ltd compare?

To compare the dividend payouts of Senores Pharmaceuticals Ltd and Shree Ganesh Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.